Video
29 Sep 2021
Dispersome® – an amorphous mixture
Content provided by our supplier
Zerion Pharma
-
DK
-
2021On CPHI since
-
1 - 24Employees
Company types
Other Content from Zerion Pharma (5)
-
Brochure Dispersome® technology published in two peer-reviewed papers
Zerion Pharma’s Dispersome® technology published in two peer-reviewed papers through partnerships with pharmaceutical companies -
Brochure New study shows that the amount of active drug in cancer tablets may be reduced
New study shows that the amount of active drug in cancer tablets may be reduced by 75% using the Dispersome® technology -
Brochure Zerion Pharma and Insud Pharma collaboration
Zerion Pharma and Insud Pharma announce collaboration to develop Dispersome® formulations of marketed drug products
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance